Electroanalytical study of fluvoxamine

Detalhes bibliográficos
Autor(a) principal: Nouws, Henri P. A.
Data de Publicação: 2005
Outros Autores: Delerue-Matos, Cristina, Barros, Aquiles A., Rodrigues, José A., Santos-Silva, Alice
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.22/2986
Resumo: Fluvoxamine (FVX) can be reduced at a mercury- drop electrode, with a maximum peak current intensity being obtained at a potential of -0.7 V vs. Ag/ AgCl, in an aqueous electrolyte solution of pH 2. The compound was determined in a pharmaceutical product and in spiked human serum by square-wave adsorptivestripping voltammetry (SWAdSV) after accumulation at the electrode surface, under batch conditions. Because the presence of dissolved oxygen did not interfere significantly with the analysis, it was also possible to determine FVX in the pharmaceutical product by use of a flow-injection analysis (FIA) system with SWAdSV detection. The methods developed were validated and successfully applied to the quantification of FVX in a pharmaceutical product. Recoveries between 76 and 89% were obtained in serum analysis. The FIA– SWAdSV method enabled analysis of up to 120 samples per hour at reduced cost, implying the possibility of competing with the chromatographic methods usually used for this analysis.
id RCAP_7a424946a829a2bd4030d832712b4165
oai_identifier_str oai:recipp.ipp.pt:10400.22/2986
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Electroanalytical study of fluvoxamineFluvoxamineSquare-wave adsorptivestripping voltammetryFlow-injection analysisElectrochemical detectionPharmaceuticalsSerumFluvoxamine (FVX) can be reduced at a mercury- drop electrode, with a maximum peak current intensity being obtained at a potential of -0.7 V vs. Ag/ AgCl, in an aqueous electrolyte solution of pH 2. The compound was determined in a pharmaceutical product and in spiked human serum by square-wave adsorptivestripping voltammetry (SWAdSV) after accumulation at the electrode surface, under batch conditions. Because the presence of dissolved oxygen did not interfere significantly with the analysis, it was also possible to determine FVX in the pharmaceutical product by use of a flow-injection analysis (FIA) system with SWAdSV detection. The methods developed were validated and successfully applied to the quantification of FVX in a pharmaceutical product. Recoveries between 76 and 89% were obtained in serum analysis. The FIA– SWAdSV method enabled analysis of up to 120 samples per hour at reduced cost, implying the possibility of competing with the chromatographic methods usually used for this analysis.Springer-VerlagRepositório Científico do Instituto Politécnico do PortoNouws, Henri P. A.Delerue-Matos, CristinaBarros, Aquiles A.Rodrigues, José A.Santos-Silva, Alice2013-11-27T12:15:27Z20052005-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.22/2986eng10.1007/s00216-005-3310-5info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-13T12:42:40Zoai:recipp.ipp.pt:10400.22/2986Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:24:00.378063Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Electroanalytical study of fluvoxamine
title Electroanalytical study of fluvoxamine
spellingShingle Electroanalytical study of fluvoxamine
Nouws, Henri P. A.
Fluvoxamine
Square-wave adsorptivestripping voltammetry
Flow-injection analysis
Electrochemical detection
Pharmaceuticals
Serum
title_short Electroanalytical study of fluvoxamine
title_full Electroanalytical study of fluvoxamine
title_fullStr Electroanalytical study of fluvoxamine
title_full_unstemmed Electroanalytical study of fluvoxamine
title_sort Electroanalytical study of fluvoxamine
author Nouws, Henri P. A.
author_facet Nouws, Henri P. A.
Delerue-Matos, Cristina
Barros, Aquiles A.
Rodrigues, José A.
Santos-Silva, Alice
author_role author
author2 Delerue-Matos, Cristina
Barros, Aquiles A.
Rodrigues, José A.
Santos-Silva, Alice
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico do Porto
dc.contributor.author.fl_str_mv Nouws, Henri P. A.
Delerue-Matos, Cristina
Barros, Aquiles A.
Rodrigues, José A.
Santos-Silva, Alice
dc.subject.por.fl_str_mv Fluvoxamine
Square-wave adsorptivestripping voltammetry
Flow-injection analysis
Electrochemical detection
Pharmaceuticals
Serum
topic Fluvoxamine
Square-wave adsorptivestripping voltammetry
Flow-injection analysis
Electrochemical detection
Pharmaceuticals
Serum
description Fluvoxamine (FVX) can be reduced at a mercury- drop electrode, with a maximum peak current intensity being obtained at a potential of -0.7 V vs. Ag/ AgCl, in an aqueous electrolyte solution of pH 2. The compound was determined in a pharmaceutical product and in spiked human serum by square-wave adsorptivestripping voltammetry (SWAdSV) after accumulation at the electrode surface, under batch conditions. Because the presence of dissolved oxygen did not interfere significantly with the analysis, it was also possible to determine FVX in the pharmaceutical product by use of a flow-injection analysis (FIA) system with SWAdSV detection. The methods developed were validated and successfully applied to the quantification of FVX in a pharmaceutical product. Recoveries between 76 and 89% were obtained in serum analysis. The FIA– SWAdSV method enabled analysis of up to 120 samples per hour at reduced cost, implying the possibility of competing with the chromatographic methods usually used for this analysis.
publishDate 2005
dc.date.none.fl_str_mv 2005
2005-01-01T00:00:00Z
2013-11-27T12:15:27Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.22/2986
url http://hdl.handle.net/10400.22/2986
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1007/s00216-005-3310-5
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer-Verlag
publisher.none.fl_str_mv Springer-Verlag
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131334743949312